117 related articles for article (PubMed ID: 24891182)
21. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
[TBL] [Abstract][Full Text] [Related]
22. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
[TBL] [Abstract][Full Text] [Related]
23. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.
Cleland JG; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC
Eur J Heart Fail; 2012 Jun; 14(6):628-34. PubMed ID: 22552183
[TBL] [Abstract][Full Text] [Related]
24. A clinical prediction rule to identify patients at heightened risk for early demise following cardiac resynchronization therapy.
Rickard J; Cheng A; Spragg D; Cantillon D; Baranowski B; Varma N; Wilkoff BL; Tang WH
J Cardiovasc Electrophysiol; 2014 Mar; 25(3):278-82. PubMed ID: 24320726
[TBL] [Abstract][Full Text] [Related]
25. [Cardiac resynchronization therapy in patients with heart failure: a 10-year experience].
Enríquez A; Barrero R; Bittner A; Frangini P; Baeza M; Millapán I; González R; Vergara I
Rev Med Chil; 2013 Aug; 141(8):968-76. PubMed ID: 24448852
[TBL] [Abstract][Full Text] [Related]
26. Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT study.
Chatterjee NA; Singh JP; Szymonifka J; Deaño RC; Thai WE; Wai B; Min JK; Januzzi JL; Truong QA
Int J Cardiol; 2016 Feb; 205():43-49. PubMed ID: 26710332
[TBL] [Abstract][Full Text] [Related]
27. Impact of Renal Function on Survival After Cardiac Resynchronization Therapy.
Kpaeyeh JA; Divoky L; Hyer JM; Daly DD; Maran A; Waring A; Gold MR
Am J Cardiol; 2017 Jul; 120(2):262-266. PubMed ID: 28545627
[TBL] [Abstract][Full Text] [Related]
28. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.
van Bommel RJ; Borleffs CJ; Ypenburg C; Marsan NA; Delgado V; Bertini M; van der Wall EE; Schalij MJ; Bax JJ
Eur Heart J; 2010 Nov; 31(22):2783-90. PubMed ID: 20693544
[TBL] [Abstract][Full Text] [Related]
29. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
30. Right ventricular function and survival following cardiac resynchronisation therapy.
Leong DP; Höke U; Delgado V; Auger D; Witkowski T; Thijssen J; van Erven L; Bax JJ; Schalij MJ; Marsan NA
Heart; 2013 May; 99(10):722-8. PubMed ID: 23315608
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
32. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.
Casado J; Montero M; Formiga F; Carrera M; Urrutia A; Arévalo JC; Pérez-Calvo JI;
Eur J Intern Med; 2013 Oct; 24(7):677-83. PubMed ID: 23830876
[TBL] [Abstract][Full Text] [Related]
34. Response to cardiac resynchronization therapy in elderly patients (≥70 years) and octogenarians.
Verbrugge FH; Dupont M; De Vusser P; Rivero-Ayerza M; Van Herendael H; Vercammen J; Jacobs L; Verhaert D; Vandervoort P; Tang WH; Mullens W
Eur J Heart Fail; 2013 Feb; 15(2):203-10. PubMed ID: 23002114
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
36. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
[TBL] [Abstract][Full Text] [Related]
37. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
[TBL] [Abstract][Full Text] [Related]
38. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
40. The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.
Aktas MK; Zareba W; Huang DT; McNitt S; Polonsky S; Chen L; Stockburger M; Merkely B; Moss AJ; Kutyifa V
J Card Fail; 2014 Mar; 20(3):183-9. PubMed ID: 24361804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
